31 results
8-K
EX-99.1
PASG
Passage Bio Inc
5 Aug 21
Passage Bio Reports Second Quarter 2021 Financial Results and Provides Recent Business Highlights
7:01am
impacted by devastating CNS disorders. Our expanded research collaboration will include the identification of relevant biological targets for genetic … upon mutual agreement. These new programs include a collaborative initial discovery phase focused on identifying relevant biological targets
8-K
PASG
Passage Bio Inc
20 Jul 23
Departure of Directors or Certain Officers
7:00am
and stipend, which bonus shall be achievable in accordance with targets established by the Company’s Board of Directors, and (iv) receive stock options
10-Q
EX-10.1
fy8rx25xylduyt
11 May 20
Quarterly report
4:06pm
S-8
EX-99.1
fluyr4 vc
19 Jul 21
Registration of securities for employees
8:01am
S-1/A
EX-10.3
efdq3cf
18 Feb 20
IPO registration (amended)
6:13am
10-K
go77y8wr6bgaz57gy
3 Mar 21
Annual report
8:01am
10-Q
dvvrbdepf504086d
11 May 20
Quarterly report
4:06pm